Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Eliades George Christopher, Director. Insider active across 2 companies, notably Oyster Point Pharma, Inc.. In total, 3 reports have been published. Activity tracked since 7 June 2021. The latest transaction was disclosed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
George Christopher Eliades is a Board Member at Oyster Point Pharma, Inc. As a board member, he participates in the governance and strategy of the company. His expertise is an asset for the organization's development.